期刊文献+

联合尿N-乙酰-β-D-氨基葡萄糖苷酶和血半胱氨酸蛋白酶抑制剂C检测在糖尿病肾病早期诊断中的意义 被引量:5

Value of combined measurement of urine N-acetyl-beta-D-glucosaminidase activity and serum Cystatin C in diagnosing diabetic nephropathy in early phase
原文传递
导出
摘要 目的探讨联合检测尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)和血半胱氨酸蛋白酶抑制剂C(CystatinC)对糖尿病肾病(DN)早期诊断的临床意义。方法62例2型糖尿病患者(糖尿病组)根据24h尿白蛋白排泄量(24hUAE)分为三组,A组(正常白蛋白尿组,24hUAE〈30mg)20例;B组(微量白蛋白尿组,24hUAE30~300mg)22例;C组(大量自蛋白尿组,24hUAE〉300nag)20例。另选择30例健康人作为对照组。收集并测定各组24hUAE、尿NAG活性,同时检测血清肌酐(SCr)及Cystalin C、采用Coekcroft—Gault公式计算内生肌酐清除率(Ccr),比较各组上述指标的变化。结果糖尿病组尿NAG活性、血清CystatinC水平均较对照组明显升高(P〈0.01),Ccr显著降低(P〈0.01);尿NAG活性、血清CystatinC水平在糖尿病分组问逐渐升高(P〈0.05或〈0.01),而SCr增高在A组、B组差异无统计学意义(P〉0.05)。糖尿病组尿NAG活性、血清CystatinC、24hUAE、SCr两两比较差异均有统计学意义,呈正相关(P〈0.01),与Ccr均呈显著负相关(P〈0.01)。尿NAG活性和血清CystatinC联合检测阳性率(80.6%,50/62)高于单项检测阳性率[分别为58.1%(36/62)和61.3%(38/62)](P〈0.05)。结论尿NAG和血清CystatinC是反映DN的敏感指标,联合检测可提高DN早期损害的检出率,有利于早期诊断。 Objective To explore the value of combined measurement of urine N-acetyl-beta-D- glucosaminidase (NAG) activity and serum Cystatin C in diagnosing dialectic nephropathy (DN) in early phase. Methods Sixty-two cases with type 2 diabetes (diabetic group) were divided into three groups according to their 24 hours urinary albumin excretion (24hUAE) :group A (normal albuminuria, 20 cases ), group B (microalbuminuria, 22 cases ) and group C (macroalbuminuria, 20 cases ). Furthermore, 30 healthy people were involved in control group. 24hUAE, NAG, serum creatinine (SCr) and serum Cystafin C were measured, and endogenous creatinine clearance rate (Ccr) was calculated by Cockcroft-Gault formula. All these indexes among three groups were compared. Results The levels of urinary NAG activity and serum Cystatin C in diabetic group was significantly higher and Ccr was significantly lower than those in control group(P 〈 0.01 ). The levels of urinary NAG activity and serum cystatin C gradually increased in group A, B and C(P〈 0.05 or 〈 0.01 ). While no significant difference was observed between group A and group B in the level of SCr (P 〉 0.05 ). There were significant positive correlations among the levels of urinary NAG activity, serum Cystatin C,24hUAE and SCr (P 〈 0.01 ),and all above showed negative correlations with Ccr (P 〈 0.01 ). Co-detection of urinary NAG activity and serum Cystatin C had significantly higher positive rate [80.6%(50/62)] than singleone [58.1%(36/62),61.3%(38/62)](P〈0.05). Conclusion Co-detection of urinary NAG activity and serum Cystatin C may indicate early renal damage in DN, and it is valuable in diagnosing DN in early phase.
出处 《中国医师进修杂志》 2010年第7期22-24,共3页 Chinese Journal of Postgraduates of Medicine
关键词 糖尿病肾病 乙酰氨基葡糖苷酶 半胱氨酸蛋白酶抑制剂C Diabetic nephropathies Acetylglucosaminidase Cystatin C
  • 相关文献

参考文献6

  • 1Futrakul N, Futrakul P. Diagnostic markers for early detectlon of diabetic retinopathy and nephropathy. Clin Nephrol,2008,69( 1 ): 63-64. 被引量:1
  • 2Mohammadi-Karakani A, Asgharzadeh-Haghighi S, Ghazi-Khansari M, et al. Determination of urinary enzymes as a marker of early renal damage in diabetic patients. J Clin Lab Anal, 2007,21 (6):413- 417. 被引量:1
  • 3Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta- analysis. Am J Kidney Dis, 2002,40(2 ) : 221-226. 被引量:1
  • 4Thomas MC, Burns WC, Cooper ME. Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis, 2005,12 (2) : 177- 186. 被引量:1
  • 5Tassi C, Abbritti G, Mancuso F, et al. Activity and isoenzyme profile of N-acetyl- beta-D-glucosaminidase in urine from workers exposed to cadmium. Clin Chim Acta, 2000,299(1/2) : 55-64. 被引量:1
  • 6Rigalleau V, Beauvieux MC, Le Moigne F, et al. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes. Diabetes Metab, 2008,34 (5) : 482-489. 被引量:1

同被引文献36

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部